Market By Product Type, Application, End-user And Geography | Forecast 2019-2028
Triton Market Research predicts that the global protein expression market is anticipated to rise with a CAGR of 11.30% during the forecast period 2019-2028. The market, that was valued at $950.67 million in the year 2019, is expected to rise to a revenue of about $2491.67 million by the year 2028.
The generation of precise proteins through biotechnological procedures is referred to as protein expression. These products are used in conducting research and designing therapeutics in medicine.
Report scope can be customized per your requirements. Request For Customization
Triton Market Research’s report on the protein expression market provides an in-depth insight into the market. The detailed analysis of the market includes key market insights, Porter’s five force analysis, key impact analysis and market attractiveness index. Â
The growing prevalence of chronic diseases, rise in healthcare expenditure and the increasing R&D in the fields of genomics and proteomics are expected to foster the growth of the market during the forecast period. The rise in healthcare expenditure significantly impacts the growth of various pharmaceutical sectors in the healthcare industry. According to the Centers for Medicare and Medicaid Services in the US, the National Health Expenditures (NHE) reached $3.3 trillion in 2016. The NHE increased by 4.3% in 2016 and accounted for 17.9% of the GDP. This growth in healthcare expenditure is expected to drive the adoption of protein expression products, which are used in the detection of various chronic diseases such as diabetes, cardiovascular diseases and others.
Emerging geographies such as India and China have been witnessing significant growth in the pharmaceutical industry. According to IQVIA Holdings Inc, the pharmaceutical industry in China is growing at 5% to 6%, while in India, it is growing at 8% to 9%, and is expected to continue the momentum for the next five years. Growing pharmaceutical markets present huge opportunities for the development of new therapies, which is expected to increase the adoption of protein expression systems. This factor is likely to, in turn, help the market grow.
As the major application of the protein expression system deals with therapies and treatment of many chronic diseases, it has to face stringent regulations. Stringent regulations present challenges in the approval process of a new protein expression system. This significantly affects the development of new products, ultimately restraining market growth. Furthermore, the high cost of protein expression systems and the lack of effective systems for post-translational modifications are some of the key restraining factors of the protein expression market.
Key geographies covered in the global protein expression market are:
•          North America: United States and Canada
•          Europe: United Kingdom, France, Germany, Spain, Italy, Russia and Rest of Europe
•          Asia-Pacific: China, Japan, India, Australia, South Korea, ASEAN Countries and Rest of Asia-Pacific
•          Latin America: Brazil, Mexico and Rest of Latin America
•          Middle East and Africa: Saudi Arabia, Turkey, United Arab Emirates, South Africa and Rest of Middle East & Africa
•          Market by Product:
o         Reagents
o         Expression
o         Competent
o         Instruments
o         Services
•          Market by Application:
o         Therapeutic
o         Industrial
o         Research
•          Market by End-user:
o         Pharmaceutical & biotechnology companies
o         Academic research institutes
o         Contract research organizations
o         Other end-users
The key companies profiled in the report include Agilent Technologies Inc, BD (Becton, Dickinson And Company), Bio-Rad Laboratories Inc, GenScript, LifeSensors, Merck KGaA, Promega Corporation, Qiagen, Takara Holdings Inc, Thermo Fisher Scientific Inc, Lonza, New England Biolabs, Biotechrabbit, ProMab and Peak Proteins Ltd.
1.   GLOBAL PROTEIN EXPRESSION MARKET - SUMMARY        Â
2.   INDUSTRY OUTLOOK
2.1. MARKET DEFINITIONÂ Â Â Â Â
2.2. KEY INSIGHTSÂ Â Â Â Â Â
2.2.1.  NORTH AMERICA HOLDS THE LARGEST MARKET SHARE        Â
2.2.2.  ASIA-PACIFIC IS THE FASTEST GROWING MARKET        Â
2.2.3.  THERAPEUTIC APPLICATIONS HOLDS THE LARGEST SHAREÂ
2.3. PORTER’S FIVE FORCE ANALYSIS  Â
2.3.1.  THREAT OF NEW ENTRANTS  Â
2.3.2.  THREAT OF SUBSTITUTE          Â
2.3.3.  BARGAINING POWER OF SUPPLIERS
2.3.4.  BARGAINING POWER OF BUYERS    Â
2.3.5.  THREAT OF COMPETITIVE RIVALRY Â
2.4. MARKET ATTRACTIVENESS INDEXÂ Â
2.5. VENDOR SCORECARDÂ
2.6. MARKET DRIVERSÂ Â Â Â Â Â Â Â Â
2.6.1.  GROWING PREVALENCE OF CHRONIC DISEASES
2.6.2.  RISE IN HEALTHCARE EXPENDITURE         Â
2.6.3.  INCREASING R&D IN THE FIELDS OF GENOMICS AND PROTEOMICS
2.7. MARKET RESTRAINTSÂ Â
2.7.1.  HIGH COST OF PROTEIN EXPRESSION SYSTEMS
2.7.2.  STRINGENT REGULATORY APPROVAL       Â
2.8. MARKET OPPORTUNITIESÂ Â Â Â Â Â Â
2.8.1.  RISE IN PHARMACEUTICAL MARKET IN EMERGING REGIONSÂ
2.9. MARKET CHALLENGES
2.9.1.  LACK OF EFFECTIVE SYSTEMS FOR POST-TRANSLATIONAL MODIFICATIONS  Â
2.10. IMPACT OF COVID-19 ON PROTEIN EXPRESSIONÂ Â Â Â Â Â Â Â
3.   GLOBAL PROTEIN EXPRESSION MARKET OUTLOOK - BY PRODUCT TYPE
3.1. REAGENTS
3.2. EXPRESSION VECTORSÂ Â Â Â Â Â Â Â Â Â Â
3.3. COMPETENT CELLSÂ Â Â Â Â Â
3.4. INSTRUMENTSÂ Â Â Â
3.5. SERVICESÂ
4.   GLOBAL PROTEIN EXPRESSION MARKET OUTLOOK - BY APPLICATION
4.1. THERAPEUTICÂ Â Â Â Â
4.2. INDUSTRIALÂ Â Â Â Â Â Â Â Â
4.3. RESEARCHÂ Â Â Â Â Â Â Â Â Â
5.   GLOBAL PROTEIN EXPRESSION MARKET OUTLOOK - BY END-USER    Â
5.1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIESÂ Â Â
5.2. ACADEMIC RESEARCH INSTITUTES
5.3. CONTRACT RESEARCH ORGANIZATIONSÂ
5.4. OTHER END-USERSÂ Â Â Â Â Â
6.   GLOBAL PROTEIN EXPRESSION MARKET – REGIONAL OUTLOOK
6.1. NORTH AMERICA
6.1.1.  MARKET BY PRODUCT TYPE   Â
6.1.2.  MARKET BY APPLICATION       Â
6.1.3.  MARKET BY END-USERÂ
6.1.4.  COUNTRY ANALYSIS     Â
6.1.4.1. UNITED STATESÂ Â Â Â Â Â Â
6.1.4.2. CANADAÂ Â Â Â Â Â Â Â Â
6.2. EUROPEÂ Â Â Â
6.2.1.  MARKET BY PRODUCT TYPE   Â
6.2.2.  MARKET BY APPLICATION       Â
6.2.3.  MARKET BY END-USERÂ
6.2.4.  COUNTRY ANALYSIS     Â
6.2.4.1. UNITED KINGDOMÂ Â Â Â
6.2.4.2. GERMANYÂ Â Â Â Â Â
6.2.4.3. FRANCEÂ Â Â Â Â Â Â Â Â Â
6.2.4.4. SPAINÂ Â
6.2.4.5. ITALYÂ Â Â Â
6.2.4.6. RUSSIA
6.2.4.7. REST OF EUROPEÂ Â Â
6.3. ASIA-PACIFICÂ Â Â Â Â Â Â
6.3.1.  MARKET BY PRODUCT TYPE   Â
6.3.2.  MARKET BY APPLICATION       Â
6.3.3.  MARKET BY END-USERÂ
6.3.4.  COUNTRY ANALYSIS     Â
6.3.4.1. CHINAÂ Â
6.3.4.2. JAPANÂ
6.3.4.3. INDIAÂ Â Â Â
6.3.4.4. SOUTH KOREAÂ Â Â Â Â Â Â Â Â
6.3.4.5. ASEAN COUNTRIES
6.3.4.6. AUSTRALIA & NEW ZEALANDÂ Â Â Â Â Â
6.3.4.7. REST OF ASIA-PACIFICÂ Â Â Â Â Â
6.4. LATIN AMERICAÂ Â
6.4.1.  MARKET BY PRODUCT TYPE   Â
6.4.2.  MARKET BY APPLICATION       Â
6.4.3.  MARKET BY END-USERÂ
6.4.4.  COUNTRY ANALYSIS     Â
6.4.4.1. BRAZIL
6.4.4.2. MEXICOÂ Â Â Â Â Â Â Â Â Â Â
6.4.4.3. REST OF LATIN AMERICAÂ
6.5. MIDDLE EAST AND AFRICAÂ Â Â Â Â
6.5.1.  MARKET BY PRODUCT TYPE   Â
6.5.2.  MARKET BY APPLICATION       Â
6.5.3.  MARKET BY END-USERÂ
6.5.4.  COUNTRY ANALYSIS     Â
6.5.4.1. UNITED ARAB EMIRATESÂ Â
6.5.4.2. TURKEYÂ Â Â Â Â Â Â Â Â Â
6.5.4.3. SAUDI ARABIAÂ Â Â Â Â Â Â Â Â Â
6.5.4.4. SOUTH AFRICAÂ Â Â Â Â Â Â Â Â
6.5.4.5. REST OF MIDDLE EAST & AFRICAÂ Â Â Â Â Â Â Â Â Â
7.   COMPETITIVE LANDSCAPE
7.1. AGILENT TECHNOLOGIES INC
7.2. BD (BECTON, DICKINSON AND COMPANY)
7.3. BIO-RAD LABORATORIES INC
7.4. GENSCRIPTÂ Â Â Â Â Â Â Â Â Â
7.5. LIFESENSORS
7.6. MERCK KGAAÂ Â Â Â Â Â Â
7.7. PROMEGA CORPORATIONÂ Â Â Â Â Â
7.8. QIAGENÂ
7.9. TAKARA HOLDINGS INC
7.10. THERMO FISHER SCIENTIFIC INC
7.11. LONZAÂ Â Â Â Â Â
7.12. NEW ENGLAND BIOLABSÂ Â Â Â Â Â Â
7.13. BIOTECHRABBITÂ Â Â Â Â Â Â Â Â Â Â
7.14. PROMABÂ Â
7.15. PEAK PROTEINS LTDÂ Â
8.   METHODOLOGY & SCOPE Â
8.1. RESEARCH SCOPE & DELIVERABLESÂ Â Â Â Â Â Â Â
8.2. SOURCES OF DATAÂ Â Â Â Â Â Â
8.3. RESEARCH METHODOLOGYÂ Â
TABLE 1: GLOBAL PROTEIN EXPRESSION MARKET, BY GEOGRAPHY, 2019-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: GLOBAL PROTEIN EXPRESSION MARKET, BY PRODUCT TYPE, 2019-2028 (IN $ MILLION)
TABLE 4: GLOBAL PROTEIN EXPRESSION MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 5: GLOBAL PROTEIN EXPRESSION MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE 6: GLOBAL PROTEIN EXPRESSION MARKET, BY GEOGRAPHY, 2019-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY PRODUCT TYPE, 2019-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE 11: EUROPE PROTEIN EXPRESSION MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 12: EUROPE PROTEIN EXPRESSION MARKET, BY PRODUCT TYPE, 2019-2028 (IN $ MILLION)
TABLE 13: EUROPE PROTEIN EXPRESSION MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 14: EUROPE PROTEIN EXPRESSION MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 16: ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY PRODUCT TYPE, 2019-2028 (IN $ MILLION)
TABLE 17: ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 18: ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE 19: LATIN AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 20: LATIN AMERICA PROTEIN EXPRESSION MARKET, BY PRODUCT TYPE, 2019-2028 (IN $ MILLION)
TABLE 21: LATIN AMERICA PROTEIN EXPRESSION MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 22: LATIN AMERICA PROTEIN EXPRESSION MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE 23: MIDDLE EAST AND AFRICA PROTEIN EXPRESSION MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 24: MIDDLE EAST AND AFRICA PROTEIN EXPRESSION MARKET, BY PRODUCT TYPE, 2019-2028 (IN $ MILLION)
TABLE 25: MIDDLE EAST AND AFRICA PROTEIN EXPRESSION MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 26: MIDDLE EAST AND AFRICA PROTEIN EXPRESSION MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
FIGURE 1: NORTH AMERICA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 2: ASIA-PACIFIC PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 3: GLOBAL PROTEIN EXPRESSION MARKET, BY THERAPEUTIC, 2019-2028 (IN $ MILLION)
FIGURE 4: PORTER’S FIVE FORCE ANALYSIS
FIGURE 5: MARKET ATTRACTIVENESS INDEX
FIGURE 6: GLOBAL PROTEIN EXPRESSION MARKET, BY REAGENTS, 2019-2028 (IN $ MILLION)
FIGURE 7: GLOBAL PROTEIN EXPRESSION MARKET, BY EXPRESSION VECTORS, 2019-2028 (IN $ MILLION)
FIGURE 8: GLOBAL PROTEIN EXPRESSION MARKET, BY COMPETENT CELLS, 2019-2028 (IN $ MILLION)
FIGURE 9: GLOBAL PROTEIN EXPRESSION MARKET, BY INSTRUMENTS, 2019-2028 (IN $ MILLION)
FIGURE 10: GLOBAL PROTEIN EXPRESSION MARKET, BY SERVICES, 2019-2028 (IN $ MILLION)
FIGURE 11: GLOBAL PROTEIN EXPRESSION MARKET, BY THERAPEUTIC, 2019-2028 (IN $ MILLION)
FIGURE 12: GLOBAL PROTEIN EXPRESSION MARKET, BY INDUSTRIAL, 2019-2028 (IN $ MILLION)
FIGURE 13: GLOBAL PROTEIN EXPRESSION MARKET, BY RESEARCH, 2019-2028 (IN $ MILLION)
FIGURE 14: GLOBAL PROTEIN EXPRESSION MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2028 (IN $ MILLION)
FIGURE 15: GLOBAL PROTEIN EXPRESSION MARKET, BY ACADEMIC RESEARCH INSTITUTES, 2019-2028 (IN $ MILLION)
FIGURE 16: GLOBAL PROTEIN EXPRESSION MARKET, BY CONTRACT RESEARCH ORGANIZATIONS, 2019-2028 (IN $ MILLION)
FIGURE 17: GLOBAL PROTEIN EXPRESSION MARKET, BY OTHER END-USERS, 2019-2028 (IN $ MILLION)
FIGURE 18: GLOBAL PROTEIN EXPRESSION MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
FIGURE 19: UNITED STATES PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 20: CANADA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 21: UNITED KINGDOM PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 22: GERMANY PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 23: FRANCE PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 24: SPAIN PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 25: ITALY PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 26: RUSSIA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 27: REST OF EUROPE PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 28: CHINA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 29: JAPAN PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 30: INDIA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 31: SOUTH KOREA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 32: ASEAN COUNTRIES PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 33: AUSTRALIA & NEW ZEALAND PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 34: REST OF ASIA-PACIFIC PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 35: BRAZIL PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 36: MEXICO PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 37: REST OF LATIN AMERICA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 38: UNITED ARAB EMIRATES PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 39: TURKEY PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 40: SAUDI ARABIA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 41: SOUTH AFRICA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
FIGURE 42: REST OF MIDDLE EAST & AFRICA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)